Gastroenterologia e Endoscopia Digestiva

css home

Telefono: 0882 410785
Fax: 0882 835411
E-Mail: f.ercolino@operapadrepio.it

Dirigente Medico Responsabile: Prof. Angelo Andriulli

Andriulli Angelo

Informazioni aggiuntive

  • Cognome Nome: Andriulli Angelo
  • Dipartimento: Scienze Mediche
  • Reparto: Gastroenterologia e Endoscopia Digestiva
  • Qualifica: Dirigente Medico
  • Incarico in CSS: Dirigente Medico Responsabile
  • Telefono Reparto: 0882410785
  • Formazione:

     

    • Laurea in Medicina e Chirurgia (1975) presso l’Università degli Studi di Torino.
    • Diploma di Specialità in Malattie dell’Apparato Digerente (1979) presso l’Università degli Studi di Torino.
  • Esperienze Professionali:

     

    • Dal 1979 al 1980 Visiting Research Assistant presso il Center for Ulcer Research and Education del Department of Medicine, School of Medicine, Veterans Administration Medical Center della University of California, Los Angeles, USA.
    • Dal 1980 al 1990 Aiuto presso la Divisione di Gastroenterologia, diretta dal Prof. Giorgio Verme, dell’Ospedale San Giovanni Battista di Torino.
    • Dal 1990 Dirigente della Struttura Complessa di Gastroenterologia ed Endoscopia Digestiva dell’Ospedale Casa Sollievo della Sofferenza.
    • E’ attualmente Professore a contratto presso la Scuola di Specializzazione in Gastroenterologia dell’Università Cattolica di Roma (Policlinico Gemelli)
  • Attività scientifica:

     

    • E’ autore di 178 pubblicazioni su riviste internazionali.
  • Società Scientifiche:

     

    Ha fatto parte in qualità di Componente del Consiglio Direttivo delle seguenti Società Scientifiche:

    • Associazione Italiana Studio Pancreas.
    • Club del Tenue;
    • Associazione Italiana Gastroenterologi Ospedalieri. Di quest’ultima Società è stato anche Presidente della Commissione Scientifica nel biennio 1998-2000.
    • Componente del Comitato Scientifico Italiano, in qualità di esperto in Gastroenterologia, di ORPHANET-ITALIA, servizio di informazioni al pubblico sulle malattie rare e farmaci orfani.
  • Pubblicazioni Scientifiche: Elenco Pubblicazioni Scientifiche

    Totale pubblicazioni a partire dal 2011: 164


    Anno

    2018; 8(1): 16389

    Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer.

    Tavano F, Gioffreda D, Valvano MR, Palmieri O, Tardio M, Latiano TP, Piepoli A, Maiello E, Pirozzi F, Andriulli A


    2018; 6(1): 92

    Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.

    Panebianco C, Andriulli A, Pazienza V


    2018; 56(9): 1400-1412

    Exploring the microbiota to better understand gastrointestinal cancers physiology.

    Panebianco C, Potenza A, Andriulli A, Pazienza V


    2018; 6(2): 225-237

    Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3.

    Morisco F, Granata R, Camera S, Ippolito A, Milella M, Conti F, Masetti C, Smedile A, Tundo P, Santantonio T, Valvano MR, Termite A, Gatti P, Messina V, Iacobellis A, Librandi M, Caporaso N, Andriulli A, ITAL-C consortium.


    2018; 154(5): 1320-1333.e10

    Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.

    Šimurina M, de Haan N, Vučković F, Kennedy NA, Štambuk J, Falck D, Trbojević-Akmačić I, Clerc F, Razdorov G, Khon A, Latiano A, D'Incà R, Danese S, Targan S, Landers C, Dubinsky M, Inflammatory Bowel Disease Biomarkers Consortium., McGovern DPB, A


    2018; 30(6): 676-681

    Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.

    Sagnelli E, Stroffolini T, Sagnelli C, Cacopardo B, Andriulli A, Babudieri S, Coppola N, Gaeta GB, Almasio PL


    2018; 53(): 79-84

    Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas.

    Andriulli A, Stroffolini T, Mariano A, Valvano MR, Grattagliano I, Ippolito AM, Grossi A, Brancaccio G, Coco C, Russello M, Smedile A, Petrini E, Martini S, Gaeta GB, Rizzetto M


    2018; ():

    Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?

    Kondili LA, Robbins S, Blach S, Gamkrelidze I, Zignego AL, Brunetto MR, Raimondo G, Taliani G, Iannone A, Russo FP, Santantonio TA, Zuin M, Chessa L, Blanc P, Puoti M, Vinci M, Erne EM, Strazzabosco M, Massari M, Lampertico P, Rumi MG, Federico A, Orlandi


    2018; ():

    The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.

    Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G, Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D'Incà R, Lionetti P, Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin MM, Cortelezzi CC, Saibeni


    2018; ():

    Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study.

    Campa D, Matarazzi M, Greenhalf W, Bijlsma M, Saum KU, Pasquali C, van Laarhoven H, Szentesi A, Federici F, Vodicka P, Funel N, Pezzilli R, Bueno-de-Mesquita HB, Vodickova L, Basso D, Obazee O, Hackert T, Soucek P, Cuk K, Kaiser J, Sperti C, Lovecek M, Ca


    2018; ():

    The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy.

    Stroffolini T, Sagnelli E, Sagnelli C, Smedile A, Furlan C, Morisco F, Coppola N, Andriulli A, Almasio PL


    2018; 81(4): 773-782

    Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice.

    Panebianco C, Adamberg K, Jaagura M, Copetti M, Fontana A, Adamberg S, Kolk K, Vilu R, Andriulli A, Pazienza V


    2018; ():

    Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.

    Obazee O, Capurso G, Tavano F, Archibugi L, De Bonis A, Greenhalf W, Key T, Pasquali C, Milanetto AC, Hackert T, Fogar P, Liço V, Dervenis C, Lawlor RT, Landoni L, Gazouli M, Zambon CF, Funel N, Strobel O, Jamroziak K, Cantù C, Malecka-Panas E, Landi S,


    2017; 8(62): 105320-105339

    MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.

    Mazza T, Copetti M, Capocefalo D, Fusilli C, Biagini T, Carella M, De Bonis A, Mastrodonato N, Piepoli A, Pazienza V, Maiello E, di Mola FF, di Sebastiano P, Andriulli A, Tavano F


    2017; ():

    Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.

    Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, Sacerdoti D, Andriulli A, Licata A, Pietrangelo A, Picardi A, Raimondo G, Violi F


    2017; 18(1): 94

    Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method.

    Chen GB, Lee SH, Montgomery GW, Wray NR, Visscher PM, Gearry RB, Lawrance IC, Andrews JM, Bampton P, Mahy G, Bell S, Walsh A, Connor S, Sparrow M, Bowdler LM, Simms LA, Krishnaprasad K, International IBD Genetics Consortium., Radford-Smith GL, Moser G


    2017; ():

    Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

    Sagnelli E, Stroffolini T, Sagnelli C, Pirisi M, Babudieri S, Colloredo G, Russello M, Coppola N, Gaeta GB, Cacopardo B, De Luca M, Almasio PL, EPACRON study group.


    2017; 12(11): e0185710

    Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.

    Stroffolini T, Sagnelli E, Andriulli A, Colloredo G, Furlan C, Gaeta GB, Morisco F, Pirisi M, Rosina F, Sagnelli C, Smedile A, Almasio PL, EPACRON study group.


    2017; ():

    Hepatitis C Virus Clearance in Older Adults.

    Ippolito AM, Iacobellis A, Milella M, Conti F, Messina V, Valvano MR, Niro GA, Morisco F, Barone M, Termite AP, Brancaccio G, Andriulli A


    2017; ():

    Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancers.

    Panebianco C, Kelman E, Vene K, Gioffreda D, Tavano F, Vilu R, Terracciano F, Pata I, Adamberg K, Andriulli A, Pazienza V


    2017; 49(2): 228-229

    Screening and treatment of portal vein thrombosis in cirrhosis.

    Senzolo M, Simioni P, Andriulli A


    2017; 29(9): 994-997

    Etiological factors of chronic hepatitis in Italy: a 2014 national survey.

    Stroffolini T, Sagnelli E, Almasio PL, Andriulli A, Smedile A, Pirisi M, Sagnelli C, Russello M, Coppola N, de Luca M, Pisaturo M, Rosina F, Gaeta GB, EPACRON study group.


    2017; 46(1): 77

    Letter: the efficacy of interferon-free regimens in HCV-related Child C cirrhosis needs careful interpretation-Authors' reply.

    Andriulli A, Guarino M, Morisco F


    2017; ():

    Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study.

    Sagnelli E, Stroffolini T, Sagnelli C, Morisco F, Coppola N, Smedile A, Pisaturo M, Colloredo G, Babudieri S, Licata A, Brancaccio G, Andriulli A, Almasio PL, Gaeta GB, EPACRON study group.


    2017; 45(3): 481-482

    Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D - authors' reply.

    Niro GA, Smedile A, Andriulli A, Rizzetto M


    2017; 262(): 179-184

    Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.

    Angelico F, Corradini SG, Pastori D, Fargion S, Fracanzani AL, Angelico M, Bolondi L, Tozzi G, Pujatti PL, Labbadia G, Corazza GR, Averna M, Perticone F, Croce G, Persico M, Bucci T, Baratta F, Polimeni L, Del Ben M, Violi F, LAL-Cirrhosis Collaborative R


    2017; 23(2): 233-243

    The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

    Fiorino G, Manetti N, Armuzzi A, Orlando A, Variola A, Bonovas S, Bossa F, Maconi G, D'Incà R, Lionetti P, Cantoro L, Fries W, Annunziata ML, Costa F, Terpin MM, Biancone L, Cortelezzi CC, Amato A, Ardizzone S, Danese S, Guidi L, Rizzuto G, Massella A, A


    2017; 45(9): 1193-1200

    Systematic review: interferon-free regimens for patients with HCV-related Child C cirrhosis.

    Guarino M, Morisco F, Valvano MR, Ippolito AM, Librandi M, Andriulli N, Greco M, Amoruso A, Iacobellis A, Niro G, Caporaso N, Andriulli A


    2017; 49(9): 1022-1028

    HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study.

    Ippolito AM, Milella M, Messina V, Conti F, Cozzolongo R, Morisco F, Brancaccio G, Barone M, Santantonio T, Masetti C, Tundo P, Smedile A, Carretta V, Gatti P, Termite AP, Valvano MR, Bruno G, Fabrizio C, Andreone P, Zappimbulso M, Gaeta GB, Napoli N, Fon


    2017; ():

    A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study.

    Barone M, Iannone A, Shahini E, Ippolito AM, Brancaccio G, Morisco F, Milella M, Messina V, Smedile A, Conti F, Gatti P, Santantonio T, Tundo P, Lauletta G, Napoli N, Masetti C, Termite AP, Francavilla R, Di Leo A, Pesce F, Andriulli A


    2017; ():

    Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.

    Campa D, Pastore M, Capurso G, Hackert T, Di Leo M, Izbicki JR, Khaw KT, Gioffreda D, Kupcinskas J, Pasquali C, Macinga P, Kaaks R, Stigliano S, Peeters PH, Key TJ, Talar-Wojnarowska R, Vodicka P, Valente R, Vashist YK, Salvia R, Papaconstantinou I, Shimi


    2017; 18(7):

    Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling.

    Palmieri O, Creanza TM, Bossa F, Latiano T, Corritore G, Palumbo O, Martino G, Biscaglia G, Scimeca D, Carella M, Ancona N, Andriulli A, Latiano A


    2017; 12(1): e0168821

    Crohn's Disease Localization Displays Different Predisposing Genetic Variants.

    Palmieri O, Bossa F, Valvano MR, Corritore G, Latiano T, Martino G, D'Incà R, Cucchiara S, Pastore M, D'Altilia M, Scimeca D, Biscaglia G, Andriulli A, Latiano A


    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY 2016; 20(12): 692-698

    Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier.

    Palmieri O, Mazza T, Castellana S, Panza A, Latiano T, Corritore G, Andriulli A, Latiano A


    2016; ():

    Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia.

    Napolitano G, Iacobellis A, Merla A, Niro G, Valvano MR, Terracciano F, Siena D, Caruso M, Ippolito A, Mannuccio PM, Andriulli A


    2016; :

    Inflammatory Bowel Disease Meets Systems Biology: A Multi-Omics Challenge and Frontier

    Palmieri O., Mazza T., Castellana S., Panza A., Latiano T., Corritore G., Andriulli A., Latiano A.

    2016; 7(): 13507

    Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease.

    Ventham NT, Kennedy NA, Adams AT, Kalla R, Heath S, O'Leary KR, Drummond H, IBD BIOM consortium., IBD CHARACTER consortium., Wilson DC, Gut IG, Nimmo ER, Satsangi J


    2016; :

    A Polymorphism of the Tnf-? Gene Promotes Steroid-Resistance In patients with Inflammatory Bowel Disease

    Palmieri O., Latiano A., Bossa F., Valvano M.R., D'incà R., Corritore G., Latiano T., Andriulli A., Annese V.

    2016; ():

    Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology.

    Stroffolini T, Sagnelli E, Gaeta GB, Sagnelli C, Andriulli A, Brancaccio G, Pirisi M, Colloredo G, Morisco F, Furlan C, Almasio PL, EPACRON study group.


    2016; ():

    Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.

    Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, Kupcinskas J, Malecka-Panas E, Neoptolemos JP, Niesen W, Vodicka P, Delle Fave G, Bas Bueno-de-Mesquita H, Gazouli M, Pacetti P, Di Leo M, Ito H, Klüter H, Soucek P, Corbo V, Yamao K, Hosono S, Kaaks


    World journal of hepatology 2016; 8(22): 949-56

    Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.

    Cleo Study Group, Ascione A, Adinolfi LE, Amoroso P, Andriulli A, Armignacco O, Ascione T, Babudieri S, Barbarini G, Brogna M, Cesario F, Citro V, Claar E, Cozzolongo R, D'Adamo G, D'Amico E, Dattolo P, De Luca M, De Maria V, De Siena M, De Vita G, Di Gia


    2016; 6(): 31549

    Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia.

    Palmieri O, Mazza T, Merla A, Fusilli C, Cuttitta A, Martino G, Latiano T, Corritore G, Bossa F, Palumbo O, Muscarella LA, Carella M, Graziano P, Andriulli A, Latiano A


    2016; ():

    The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.

    Salerno F, Borzio M, Pedicino C, Simonetti R, Rossini A, Boccia S, Cacciola I, Burroughs AK, Manini MA, La Mura V, Angeli P, Bernardi M, Dalla Gasperina D, Dionigi E, Dibenedetto C, Arghittu M, AISF Investigators


    Alimentary pharmacology and therapeutics 2016; ():

    HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response.

    Niro GA, Smedile A, Fontana R, Olivero A, Ciancio A, Valvano MR, Pittaluga F, Coppola N, Wedemeyer H, Zachou K, Marrone A, Fasano M, Lotti G, Andreone P, Iacobellis A, Andriulli A, Rizzetto M


    2016; ():

    Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.

    Violi F, Corazza RG, Caldwell SH, Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone L, Vestri A, Raparelli V, Basili S, PRO-LIVER Collaborators


    2016; ():

    Transperineal ultrasonography: First level exam in IBD patients with perianal disease.

    Terracciano F, Scalisi G, Bossa F, Scimeca D, Biscaglia G, Mangiacotti M, Valvano MR, Perri F, Simeone A, Andriulli A


    2016; ():

    Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference.

    Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI)


    2016; 43(1): 174-5

    Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma.

    Bossa F, Perri F, Niro G, Parente P, Graziano P, Andriulli A


    2016; ():

    Metabolomic profile in pancreatic cancer patients: a consensusbased approach to identify highly discriminating metabolites.

    Di Gangi IM, Mazza T, Fontana A, Copetti M, Fusilli C, Ippolito A, Mattivi F, Latiano A, Andriulli A, Vrhovsek U, Pazienza V


    2016; 45(4): 626-9

    Support Vector Machine Based on microRNA Expression Profiles to Predict Histological Origin of Ampullary Carcinoma: Case Report of a Patient Affected From Adenocarcinoma of the Papilla of Vater With Lynch Syndrome.

    Tavano F, Copetti M, Piepoli A, Carella M, Gentile A, Burbaci FP, Fontana A, De Bonis A, di Mola FF, di Sebastiano P, Andriulli A


    2016; ():

    Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients.

    Fontana A, Copetti M, Di Gangi IM, Mazza T, Tavano F, Gioffreda D, Mattivi F, Andriulli A, Vrhovsek U, Pazienza V


    2015; : e257

    Whole exome sequencing of very early onset ulcerative colitis patients identifies new variants in candidate genes

    Palmieri O., Aloi M., Prudente S., Mazza T., Stronati L., Corritore G., Latiano T., Bossa F., Andriulli A., Cucchiara S., Latiano A.

    2015; 6(): 8019

    International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.

    Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D, Canadian-US PBC Consortium, Italian PBC Genetics Study Group, UK-PBC Consortium, Gershwin ME, Anderson CA, Lazarid


    2015; ():

    Hepatitis viruses exploitation of host DNA methyltransferases functions.

    Pazienza V, Panebianco C, Andriulli A


    2015; (): 1-14

    Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome.

    Palmieri O, Mazzoccoli G, Bossa F, Maglietta R, Palumbo O, Ancona N, Corritore G, Latiano T, Martino G, Rubino R, Biscaglia G, Scimeca D, Carella M, Annese V, Andriulli A, Latiano A


    2015; ():

    Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease.

    Palmieri O, Creanza TM, Bossa F, Palumbo O, Maglietta R, Ancona N, Corritore G, Latiano T, Martino G, Biscaglia G, Scimeca D, De Petris MP, Carella M, Annese V, Andriulli A, Latiano A


    Minerva gastroenterologica e dietologica 2015; 61(1): 1-9

    Value of real-time gastric juice analysis in upper gastrointestinal endoscopy.

    Ummarino A, Tucci FA, Pezzicoli G, Di Virgilio AP, Parigino D, Tucci P, Bisceglia M, Rugge M, Tucci A, Andriulli A


    2015; (): 1-16

    SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation.

    Tavano F, Pazienza V, Fontana A, Burbaci FP, Panebianco C, Saracino C, Lombardi L, De Bonis A, di Mola FF, di Sebastiano P, Piepoli A, Vinciguerra M, Fracavilla M, Giuliani F, Rubino R, Andriulli A, Mazzoccoli G


    2015; 9(1): 52-7

    HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome.

    Andriulli A, Morisco F, Ippolito AM, Di Marco V, Valvano MR, Angelico M, Fattovich G, Granata R, Smedile A, Milella M, Felder M, Gaeta GB, Gatti P, Fasano M, Mazzella G, Santantonio T


    2014; 60 (4): 1102A

    Long-Term HDV-RNA Suppression ? HBsAg Clearance in Chronic Hepatitis D Following Interferon Therapy

    Niro G.A., smedile A., Fontana R., Olivero A., Ciancio A., Pittalunga F., Coppola N., Wedemeyer H., Zachou K., Marrone A., Fasano M., Santantonio T., Lotti G., Andriulli A., Rizzetta M.

    2014; :

    Transperineal ultrasound (TPUS) in pediatric perianal disease

    Terracciano F., Scalisi G., Pastore M., D'Altilia M., Andriulli A., Sacco M., Sacco E.

    2014; 34(9): 1369-77

    Variation in genes encoding for interferon ?-3 and ?-4 in the prediction of HCV-1 treatment-induced viral clearance.

    Palmieri O, Ippolito AM, Margaglione M, Valvano MR, Gioffreda D, Fasano M, D'Andrea G, Corritore G, Milella M, Andriulli N, Morisco F, Giannitrapani L, Latiano A, Fontana R, Gatti P, Tundo P, Barone M, Cozzolongo R, Santantonio T, Andriulli A


    2014; ():

    Detection of Gastric Precancerous Conditions in Daily Clinical Practice: A Nationwide Survey.

    Lahner E, Zullo A, Hassan C, Perri F, Dinis-Ribeiro M, Esposito G, Di Giulio E, Buscarini E, Bianco MA, De Boni M, MAG-Study Group, Annibale B


    2014; 12(1): 248

    Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.

    Tavano F, Fontana A, Pellegrini F, Burbaci F, Rappa F, Cappello F, Copetti M, Maiello E, Lombardi L, Graziano P, Vinciguerra M, di Mola F, di Sebastiano P, Andriulli A, Pazienza V


    2014; 46(9): 799-815

    Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Updated June 2014.

    Dumonceau JM, Andriulli A, Elmunzer BJ, Mariani A, Meister T, Deviere J, Marek T, Baron TH, Hassan C, Testoni PA, Kapral C


    2014; 46(9): 818-25

    An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C.

    Andriulli A, Nardi A, Di Marco V, Ippolito AM, Gavrila C, Aghemo A, Di Paolo D, Squadrito G, Grassi E, Calvaruso V, Valvano MR, Brancaccio G, Craxi A, Angelico M, Collaborators, Collaborators


    2014; ():

    Overall acceptability and efficacy of commonly used bowel preparations for colonoscopy in Italian clinical practice. A multicentre prospective study.

    Parente FR, Repici A, Crosta C, Cipolletta L, Testoni PA, Costamagna G, Andriulli A, Di Matteo G, Sassatelli R, Gallus S


    2014; 60: S312

    Hcv genotype 1a and 1b: similarities and differences in clinical features, therapeutic outcome and predictors of response

    F. Morisco, V. Di Marco, R. Granata, S. Camera, Ippolito A, M. Margaglione, G. Fattovich, A. Smedile, E. Clery, C. Ferraiuoli, M. Guarino, L. Donnarumma, Valvano MR, M. Milella, M.M. Felder, G.B. Gaeta, P. Gatti, P. Tundo, M. Barone, R. Cozzolongo, M. Ang

    2014; 60: S456

    A model to estimate a priori the probability of sustained virological response to peg-interferon and ribavirin for patients with hcv-1 infection

    Andriulli A, Angelico M, Nardi, Ippolito A.M., C. Gravila, V. Calvaruso, Valvano M.R., V. Di Marco, A. Craxì.

    United European Gastroenterology 2014; 2(2): 138-147

    Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation

    Neri L., Basilisco G., Corazziari E., Stanghellini V., Bassotti G., Bellini M., Perelli I., Cuomo R. and LIRS Study Group

    ViroVIP 2014; :

    Peg-interferone alfa-2b vs peg-interferone alfa-2a: una vexata questio

    Andriulli A., Favale R.A., Andriulli N.

    2014; 46S: S123

    Clinical Features, Therapeutic Outcome And Predictor Of Response In HCV Genotype 1A And 1B: Similarities And Differences

    Morisco F., Di Marco V., Caporaso N., Granata R., Camera S., Ippolito A., Margaglione M., Fattovich G., Smedile A., Clery E., Ferraiuoli C., Cossiga V., Guarino M., Donnarumma L., Valvano M.R., Milella M., Felder M.M., Gaeta G.B., Gatti P., Tundo P., Baro

    2014; 46S: S12

    A model to predict success following peg-interferon and ribavirin therapy for patients with HCV-1 infection

    Ippolito A.M., Andriulli A., Angelico M., Nardi A., Di Marco V., Smedile A., Calvaruso V., Valvano M.R., Milella M., Morisco F., Fattovich G., Felder M., Brancaccio G., Fasano M., Gatti P., Andriulli N., Tundo P., Barone M., Cozzolongo R., D'Andrea G., Ma

    2014; 46s: s3

    Management of HCC in elderly patients: an italian "in field" experience

    Dionigi E., Borzio M., Rossini A., Toldi A., Francica G., Fornari F., Salmi A., Farinati F., Vicari S., Marignani M., Andriulli A., Ginanni B., Sacco R.

    2014; ():

    Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: single centre experience.

    di Mola FF, Tavano F, Rago RR, De Bonis A, Valvano MR, Andriulli A, di Sebastiano P


    2014; 46S: S20

    Results of a screening program devoted to first degree relatives of crc patients: 3 years experience

    Biscaglia G., Nardella M., Andriulli A.

    2014; ():

    Reply to "Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools"

    Palmieri O, Valvano MR, Margaglione M, Andriulli A


    2014; ():

    Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia.

    Iacobellis A, Cozzolongo R, Minerva N, Valvano MR, Niro GA, Fontana R, Palmieri O, Ippolito A, Andriulli A


    2014; 20(10): 2624-2633

    Hepatitis C virus, mitochondria and auto/mitophagy: Exploiting a host defense mechanism.

    Ruggieri V, Mazzoccoli C, Pazienza V, Andriulli A, Capitanio N, Piccoli C


    2014; 75(4): 364-9

    Impact of genetic polymorphisms on the pathogenesis of idiopathic achalasia: Association with IL33 gene variant.

    Latiano A, Palmieri O, Bossa F, Latiano T, Corritore G, De Santo E, Martino G, Merla A, Valvano MR, Cuttitta A, Mazza T, Annese V, Andriulli A


    Biochimica et Biophysica Acta 2014; (): 1-12

    Peroxisome proliferator-activated receptor ?-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.

    Panza A, Votino C, Gentile A, Valvano MR, Colangelo T, Pancione M, Merla G, Andriulli A, Sabatino L, Vinciguerra M, Mazzoccoli G, Colantuoni V, Piepoli A


    2014; 9(1): e87075

    Loss of connectivity in cancer co-expression networks.

    Anglani R, Creanza TM, Liuzzi VC, Piepoli A, Panza A, Andriulli A, Ancona N


    2014; 6(1): 1-13

    SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation.

    Pazienza V, Borghesan M, Mazza T, Sheedfar F, Panebianco C, Williams R, Mazzoccoli G, Andriulli A, Nakanishi T, Vinciguerra M


    2013; 19(47): 8902-8909

    Exploitation of host clock gene machinery by hepatitis viruses B and C.

    Vinciguerra M, Mazzoccoli G, Piccoli C, Tataranni T, Andriulli A, Pazienza V


    2013; : S193-S194

    A multicentre prospective observational study assessing acceptability and efficacy of most commonly used bowel cleansing preparations for colonoscopy in clinical practice in Italy

    Parente F., Repici A., Crosta C., Cipolletta L., Testoni P.A., Costamagna G., Andriulli A., DiMatteo G., Sassatelli R., Gallus S.

    XVI Congresso Nazionale SIGU 2013; : 15

    MicroRNA-139-5p regulates human TIM expression in colon cancer cell lines

    Panza A., Gentile A., Valvano R., Augello B., Tavano F., Merla G., Guarnieri V., Andriulli A., Mazzoccoli G., Piepoli A.

    XVI Congresso Nazionale SIGU 2013; : P273

    Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin

    Palmieri O., D'andrea G., De Girolamo G., Di Marco V., Margaglione M., Ippolito A.M., Fattovich G., Smedile A., Valvano M.R., Calvaruso V., Gioffreda D., Milella M., Morisco F., Felder M., Brancaccio G., Fasano M., Gatti P., Tundo P., Barone M., Cozzolong

    2013; : S-471

    Genetic Risk Profiling of Complicated Disease Course in Crohn's Disease Patients

    Latiano A., Palmieri O., Buccianti N., Scimeca D., Biscaglia G., Valvano M.R., D'Incà R., Annese V., Andriulli A.

    2013; 45: S56

    Hepatitis delta virus (HDV) induces specific DNA methylation events towards malignancy in hepatoma cells

    Benegiamo G., Vinciguerra M., Guarnieri V., Niro G.A., Andriulli A., Pazienza V.

    AISD - 36° Congresso Nazionale 2013; : 55

    Safety and efficacy of effentora to treat acute moderate oncological pain in a cirrhotic patient without previous strong opioid therapy

    Latina P., Andriulli A., Niro A., Conoscitore P., Ippolito A., Nardella M., Iacobellis A.

    2013; 19(44): 7930-7946

    Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian association for the study of the pancreas.

    Pezzilli R, Andriulli A, Bassi C, Balzano G, Cantore M, Delle Fave G, Falconi M, the Exocrine Pancreatic Insufficiency collaborative (EPIc) Group


    2013; 45(12): 1003-10

    Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases.

    Tavano F, Palmieri O, di Mola FF, Latiano A, Burbaci FP, Valvano MR, Corritore G, Augello B, Merla G, Annese V, Andriulli A, di Sebastiano P


    Società Italiana di Genetica Umana - XVI Congresso Nazionale 2013; : P321

    The TT/-G frameshift variant of the novel IFNL4 gene not improves HCV1 clearance prediction

    Palmieri O., D'andrea G. , Ippolito A.M., De Girolamo G. , Margaglione M., Latiano A., Valvano M.R., Gioffreda D., Fasano M., Milella M., Morisco F., Montalto G., Gatti P., Tundo P., Barone M., Cozzolongo R., Santantonio T., Andriulli A.

    Journal of the Pancreas 2013; 14(6): 618-25

    Neoadjuvant chemo-radiotherapy for patients with borderline resectable pancreatic cancer: a meta-analytical evaluation of prospective studies.

    Festa V, Andriulli A, Valvano MR, Uomo G, Perri F, Andriulli N, Corrao S, Koch M


    2013; 60(1): 16-21

    Identification of Naïve Hcv-1 Patients with Chronic Hepatitis who may Benefit from Dual Therapy with Peg-Interferon and Ribavirin.

    Andriulli A, Marco VD, Margaglione M, Ippolito AM, Fattovich G, Smedile A, Valvano MR, Calvaruso V, Gioffreda D, Milella M, Morisco F, Felder M, Brancaccio G, Fasano M, Gatti P, Tundo P, Barone M, Cozzolongo R, Angelico M, D'Andrea G, Andriulli N, Abate M


    Minerva Gastroenterologica e dietologica 2013; 59(1): 97-105

    Perendoscopic real-time assessment of pH improves detection of gastric preneoplastic conditions.

    Pezzicoli G, Tucci FA, Ummarino A, Tucci P, Di Virgilio AP, Bisceglia M, Rugge M, Tucci A, Andriulli A


    2013; 20(7): 502-9

    Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.

    Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A


    2013; 114(1): 64-8

    Affinity analysis of differentially expressed genes in hepatocytes expressing HCV core genotype 1b or 3a.

    Mazza T, Castellana S, Andriulli A, Auffray C, Vinciguerra M, Pazienza V


    2013; 19(9): 1872-9

    Erythrocytes-mediated Delivery of Dexamethasone 21-phosphate in Steroid-dependent Ulcerative Colitis: A Randomized, Double-blind Sham-controlled Study.

    Bossa F, Annese V, Valvano MR, Latiano A, Martino G, Rossi L, Magnani M, Palmieri O, Serafini S, Damonte G, De Santo E, Andriulli A


    2013; 587(9): 1424-8

    Hepatitis delta virus induces specific DNA methylation processes in Huh-7 liver cancer cells.

    Benegiamo G, Vinciguerra M, Guarnieri V, Niro GA, Andriulli A, Pazienza V


    2013; 51(9): 1707-17

    Advance in molecular diagnostic tools for hepatitis B virus detection.

    Pazienza V, Niro GA, Fontana R, Vinciguerra M, Andriulli A


    2013; 8(4): e62144

    Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease.

    Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro TT, Bossa F, Merla G, Augello B, Latiano T, Corritore G, Settesoldi A, Valvano MR, D'Incà R, Stronati L, Annese V, Andriulli A


    2013; 8(4): e60527

    Mutual Antagonism between Circadian Protein Period 2 and Hepatitis C Virus Replication in Hepatocytes.

    Benegiamo G, Mazzoccoli G, Cappello F, Rappa F, Scibetta N, Oben J, Greco A, Williams R, Andriulli A, Vinciguerra M, Pazienza V


    2013; 1833(8): 1853-65

    Interplay between SOX9, ?-catenin and PPAR? activation in colorectal cancer.

    Panza A, Pazienza V, Ripoli M, Benegiamo G, Gentile A, Valvano MR, Augello B, Merla G, Prattichizzo C, Tavano F, Ranieri E, Sebastiano PD, Vinciguerra M, Andriulli A, Mazzoccoli G, Piepoli A


    2013; 2013 - suppl 1: s 278 - p667

    Dissecting the role of unfolded protein response pathway in inflammatory bowel disease: in silico mRNA-miRNA co-expression analysis

    Palmieri O, Bossa F, Creanza MT, Latiano T, Corritore G, Scimeca D, Biscaglia G, Liuzzi VC, Anglani R, Carella M, Annese V, Andriulli A, Latiano A

    2013; 45(7): 606-11

    Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: Results of an Italian multicenter study.

    Resta N, Pierannunzio D, Lenato GM, Stella A, Capocaccia R, Bagnulo R, Lastella P, Susca FC, Bozzao C, Loconte DC, Sabbà C, Urso E, Sala P, Fornasarig M, Grammatico P, Piepoli A, Host C, Turchetti D, Viel A, Memo L, Giunti L, Stigliano V, Varesco L, Berta


    2013; 62(2): 290-8

    Randomised study comparing 48 and 96 weeks peginterferon ?-2a therapy in genotype D HBeAg-negative chronic hepatitis B.

    Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M, PegBeLiver Study Group


    2013; 14(3): 179-86

    Pathway-based analysis of primary biliary cirrhosis genome-wide association studies.

    Kar SP, Seldin MF, Chen W, Lu E, Hirschfield GM, Invernizzi P, Heathcote J, Cusi D, the Italian PBC Genetics Study Group, Almasio PL, Alvaro D, Andreone P, Andriulli A, Barlassina C, Benedetti A, Bernuzzi F, Bianchi I, Bragazzi M, Brunetto M, Bruno S, Cal


    2013; 9(2): 283-94

    Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study.

    Borzio M, Fornari F, De Sio I, Andriulli A, Terracciano F, Parisi G, Francica G, Salvagnini M, Marignani M, Salmi A, Farinati F, Carella A, Pedicino C, Dionigi E, Fanigliulo L, Cazzaniga M, Ginanni B, Sacco R


    XIV National Congress of Medical Oncology 2012; 27/29 ottobre 2012: S41 - B42

    Chemokine receptor CXCR4: what is its role in gastrointestinal cancer?

    Lombardi L, Tavano F, Piepoli A, Di Maggio G, Latiano TP, Nanni L, Andriulli A, Di Sebastiano P, Maiello E

    2012; 12(): 608

    Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colon.

    Maglietta R, Liuzzi VC, Cattaneo E, Laczko E, Piepoli A, Panza A, Carella M, Palumbo O, Staiano T, Buffoli F, Andriulli A, Marra G, Ancona N


    2012; ():

    Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium.

    Campa D, Rizzato C, Capurso G, Giese N, Funel N, Greenhalf W, Soucek P, Gazouli M, Pezzilli R, Pasquali C, Talar-Wojnarowska R, Cantore M, Andriulli A, Scarpa A, Jamroziak K, Fave GD, Costello E, Khaw KT, Heller A, Key TJ, Theodoropoulos G, Malecka-Panas


    2012; ():

    Estimates of HCV-1 Patients Attaining RVR Following Dual Therapy with Peg-Interferon and Ribavirin.

    Andriulli A, Iacobellis A, Valvano MR, Spirito F, Ippolito A, Bossa F, Terracciano F, Fontana R, Niro G


    2012; 41(8): 1355-6

    Preoperative Biliary Drainage and Surgical Outcome After Pancreaticoduodenectomy

    Di Mola FF, Tavano F, De Bonis A, Grottola T, Tardio M, Valvano MR, Andriulli A, Di Sebastiano P

    PANCREATOLOGY - 44th European Pancreatic Club (EPC) Meeting 2012; : P81

    Neoadjuvant chemo-radiotherapy for Patients with Borderline Resectable Pancreatic Cancer: A Meta-analytical evaluation of Prospective Studies

    Festa V, Andriulli A, Valvano MR, Uomo G, Perri F, Corrao S, Koch M

    JOP. J Pancreas - AISP - 36th National Congress 2012; 13(5 Suppl): 644

    Changes in MicroRNAs Expression and Clinical Associations in Patients with Neuroendocrine Pancreatic Tumors

    Tavano F, di Mola F, Burbaci F, Lombardi L, Copetti M, Piepoli A, Andriulli A, Maiello E, di Sebastiano P

    XIV Congresso Nazionale AIOM 2012; :

    Chemokine receptor cxcr4: what is its role in gastrointestinal cancer?

    Lombardi L, Tavano F, Piepoli A, Di Maggio G, Latiano TP, Nanni L, Andriulli A,di Sebastiano P, Maiello E.

    2012; 367(16): 1519-28

    Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

    Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG, CERTIFI Study Group


    2012; :

    Epidemiology and diagnosis of hepatitis D virus

    Niro GA, Fontana R, Ippolito AM, Andriulli A

    2012; 237(10): 1123-8

    The expression of leucine-rich repeat gene family members in colorectal cancer.

    Piepoli A, Palmieri O, Maglietta R, Panza A, Cattaneo E, Latiano A, Laczko E, Gentile A, Carella M, Mazzoccoli G, Ancona N, Marra G, Andriulli A


    2012; 36(8): 717-24

    Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations.

    Repici A, Cestari R, Annese V, Biscaglia G, Vitetta E, Minelli L, Trallori G, Orselli S, Andriulli A, Hassan C


    2012; 21(23): 5209-5221

    Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

    Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, Kosoy R, Ransom M, Sun Y, Bianchi I, Schlicht EM, Lleo A, Coltescu C, Bernuzzi F, Podda M, Lammert C, Shigeta R, Chan LL, Balschun T, Marconi M, Cusi D, Mason AL, Myers RP, Milkiewicz P, Od


    2012; 2012(): 461784

    Correlations among PPAR?, DNMT1, and DNMT3B Expression Levels and Pancreatic Cancer.

    Pazienza V, Tavano F, Benegiamo G, Vinciguerra M, Burbaci FP, Copetti M, di Mola FF, Andriulli A, di Sebastiano P


    2012; 41(8): 1280-4

    Changes in miR-143 and miR-21 Expression and Clinicopathological Correlations in Pancreatic Cancers.

    Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, Latiano T, Pellegrini F, Maiello E, Andriulli A, di Sebastiano P


    2012; 2012(): 890875

    Time-Qualified Patterns of Variation of PPAR?, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines.

    Pazienza V, Tavano F, Francavilla M, Fontana A, Pellegrini F, Benegiamo G, Corbo V, di Mola FF, Di Sebastiano P, Andriulli A, Mazzoccoli G


    2012; 29(8): 994-1003

    Association Study of a Polymorphism in Clock Gene PERIOD3 and Risk of Inflammatory Bowel Disease.

    Mazzoccoli G, Palmieri O, Corritore G, Latiano T, Bossa F, Scimeca D, Biscaglia G, Valvano MR, D'Incà R, Cucchiara S, Stronati L, Annese V, Andriulli A, Latiano A


    2012; 44(11): 952-6

    A unifying working hypothesis for Juvenile polyposis syndrome and Ménétrier's disease: Specific localization or concomitant occurrence of a separate entity?

    Piepoli A, Mazzoccoli G, Panza A, Tirino V, Biscaglia G, Gentile A, Valvano MR, Clemente C, Desiderio V, Papaccio G, Bisceglia M, Andriulli A


    2012; 13(6): 461-468

    Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis.

    Invernizzi P, Ransom M, Raychaudhuri S, Kosoy R, Lleo A, Shigeta R, Franke A, Bossa F, Amos CI, Gregersen PK, Siminovitch KA, Cusi D, de Bakker PI, Podda M, Gershwin ME, Seldin MF, The Italian PBC Genetics Study Group


    2012; 367(8): 716-24

    Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.

    Afdhal NH, Giannini EG, Tayyab G, Mohsin A, Lee JW, Andriulli A, Jeffers L, McHutchison J, Chen PJ, Han KH, Campbell F, Hyde D, Brainsky A, Theodore D, ELEVATE Study Group


    2012; 18th Congress of Digestive Diseases - 44s P.05.13: s115-s116

    Infliximab versus adalimumab in crohn's disease patients in daily clinical practice. A prospective single center experience_

    Bossa F, Annese V, Scimeca D, Biscaglia G, Colombo E, Martino G, De Santo E, Andriulli A

    2012; 57(6): 1598-603

    DNA methyltransferases 1 and 3b expression in huh-7 cells expressing HCV core protein of different genotypes.

    Benegiamo G, Vinciguerra M, Mazzoccoli G, Piepoli A, Andriulli A, Pazienza V


    2012; 44-p.12.6: s162

    Adherence to screening colonoscopy in a high risk population, first-degree relatives of patients with colorectal cancer

    Biscaglia G, Nardella M, Andriulli A

    2012; 6-p291: s126

    Infliximab versus adalimumab in Crohn's disease patients in daily clinical practise. A prospective single center experience

    Bossa F, Annese V, Scimeca D, Biscaglia G, Colombo E, Martino G, De Santo E, Andriulli A

    2012; 6-p448: s187

    Polymorphism in IL-33, IL1RL1 genes and risk of inflammatory bowel disease

    Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro T, Bossa F, Merla G, Augello B, Valvano MR, D'Incà R, Cucchiara S, Annese V, Andriulli A,

    2012; 6(5): 563-70

    Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels.

    Tavano F, di Mola FF, Latiano A, Palmieri O, Bossa F, Valvano MR, Latiano T, Annese V, Andriulli A, di Sebastiano P


    2012; 56: s174

    Hepatitis Delta Virus upregulates DNMT3B through STAT3 activation in HUH-7 cells

    Benegiamo G, Vinciguerra M, Mazzoccoli G, Guarnieri V, Niro G, Andriulli A, Pazienza V

    2012; 56: s426

    PEG-interferon and ribavirin in HCV-related cirrhotic patients with profound thrombocytopenia

    Andriulli A, Iacobellis A, Iannacone C, Angarano G, Adinolfi A, Persico M, Mangia A, Fattovich G, Capra F, Rizzetto M, Golotta C

    2012; 56: s427

    A substantial proportion of naive HCV-1 infected patients with chronic infection may benefit from current standard therapy with PEG-interferon and ribavirin

    Andriulli A, Valvano MR, Spirito F, Ippolito A, Iacobellis A, Bossa F, Terracciano F, Niro G

    2012; 56: S262

    Hemorrhagic complications following invasive procedures in cirrhotic patients with normal or abnormal coagulopathy. A prospective study

    Napolitano G, Valvano MR, Caruso N, Merla A, Lauriola W, Ippolito A, Siena D, Niro G, Florio F, Andriulli A

    2012; 7(3): e33663

    Mirna expression profiles identify drivers in colorectal and pancreatic cancers.

    Piepoli A, Tavano F, Copetti M, Mazza T, Palumbo O, Panza A, di Mola FF, Pazienza V, Mazzoccoli G, Biscaglia G, Gentile A, Mastrodonato N, Carella M, Pellegrini F, di Sebastiano P, Andriulli A


    The Eurasian Journal of Medicine 2011; 43(3): 133-40

    Fundoplication after heller myotomy: a retrospective comparison between nissen and dor.

    Cuttitta A, Tancredi A, Andriulli A, De Santo E, Fontana A, Pellegrini F, Scaramuzzi R, Scaramuzzi G


    THE EURASIAN JOURNAL OF MEDICINE 2011; :

    Fundoplication After Heller Myotomy: A Retrospective

    Cuttitta A., Tancredi A., Andriulli A., De Santo E., Fontana A., Pellegrini F., Scaramuzzi R., Scaramuzzi G.

    2011; 43 Suppl 2 UCTN(): E419

    Closure of a gastrocutaneous fistula by a tulip-bundle technique.

    Perri F, Gentile M, Scimeca D, Terracciano F, Merla A, Spirito F, Andriulli A


    2011; 43 Suppl 2 UCTN(): E408-9

    Endoscopic removal of gallstone impacted in the rectum.

    Perri F, Terracciano F, Gentile M, Merla A, Scimeca D, Andriulli A


    2011; ():

    ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.

    Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Piepoli A


    2011; 6(7): e22688

    Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients.

    Latiano A, Palmieri O, Latiano T, Corritore G, Bossa F, Martino G, Biscaglia G, Scimeca D, Valvano MR, Pastore M, Marseglia A, D'Incà R, Andriulli A, Annese V


    2011; :

    SIRT1 and the Clock Gene Machinery in Colorectal Cancer

    Pazienza V, Piepoli A, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Mazzoccoli M


    2011; 396(3): 345-51

    A modified fast-track program for pancreatic surgery: a prospective single-center experience.

    di Sebastiano P, Festa L, De Bonis A, Ciuffreda A, Valvano MR, Andriulli A, di Mola FF


    XIV Congresso Nazionale della Società  Italiana di Genetica Umana 2011; : 486

    MicroRNA-145 regulates human SOX9 expression in colon cancer cell lines

    A. Piepoli, A. Panza, V. Pazienza, A. Gentile, G. Mazzoccoli, G. Benegiamo, G. Biscaglia, F. Tavano, N. Mastrodonato, P. Di Sebastiano, Andriulli A.

    2011; :

    Abstract E25 - XIII Congresso Nazionale di Oncologia Medica, Bologna 2011

    Piepoli A et al.

    2011; 28(10): 841-51

    Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients.

    Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P, Andriulli A, Piepoli A


    2011; 54(4): 605A

    Long-Term Outcome Of Liver Disease In Patients With Hbv-Related Chronic Hepatitis Under Protracted Nucleos(T)Ide Analogs

    Niro GA et al.

    2011; 54(4): 1077A

    Kinetics Of Hdv-Rna And Hepatitis B Surface Antigen In Chronic Delta Hepatitis Under Pegylated Interferon And/Or Nucleoside Analogs Therapy

    Olivero et al.

    2011; 54(4): 403A-404A

    Treatment Of Patients With Acute Hcv Monoinfection May Be Delayed After Week 24 According With Il28b Single Nucleotide Polymorphisms (Snp) Results And Independently Of Hepatitis C Virus (Hcv) Genotype

    Mangia A. et al.

    2011; ():

    Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies.

    Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, Maisonneuve P, Sebastiano PD


    2011; 43(s1): A333

    Low volume bowel preparation for colonoscopy: a comparison between peg-cs and bisacodyl vs peg-asc

    A. Repici, R. Cestari, V. Annese, G. Biscaglia, S. Morini, A. San Romerio, G. Brunetti, E. Vitetta, L. Minelli, G. Trallori, C. Hassan, A. Andriulli

    2011; :

    MicroRNA and Colon-Cancer: The Circadian Clock Connection

    Ada Piepoli, Anna Panza, Gianluigi Mazzoccoli, Massimiliano Copetti, Orazio Palumbo, Massimo Carella, Annamaria Gentile, Valerio Pazienza, Francesca Tavano, Nicola Mastrodonato, Giuseppe Biscaglia, Fabio Pellegrini, Pierluigi Di Sebastiano, Angelo Andriul

    2011; AGA Abstracts: S-272

    Dissection of the Crohn's Disease Transcriptome of 71 Loci Using Genome-Wide Microarrays

    Orazio Palmieri, Anna Latiano, Rosalia Maglietta, Orazio Palumbo, Giuseppe Corritore, Tiziana Latiano, Giuseppina Martino, Massimo Carella, Nicola Ancona, Fabrizio Bossa, Angelo Andriulli, Vito Annese

    2011; : S161

    Whole-transcript human gene expression pathway analysis in Crohn's disease

    O. Palmieri, A. Latiano, R. Maglietta, B. Fabrizio, D. Scimeca, G. Biscaglia, O. Palumbo, M. Carella, N. Ancona, A. Andriulli, V. Annese

    2011; 18(7): e206-11

    Unawareness of HBV infection among inpatients in a Southern Italian hospital.

    Ippolito AM, Niro GA, Fontana R, Lotti G, Gioffreda D, Valvano MR, Iacobellis A, Di Mauro L, Stroffolini T, Andriulli A


    2011; 364(19): 1807-16

    Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia.

    Boeckxstaens GE, Annese V, des Varannes SB, Chaussade S, Costantini M, Cuttitta A, Elizalde JI, Fumagalli U, Gaudric M, Rohof WO, Smout AJ, Tack J, Zwinderman AH, Zaninotto G, Busch OR, European Achalasia Trial Investigators


    2011; ():

    IL23R, ATG16L1, IRGM, OCTN1, and OCTN2 mRNA expression in inflamed and noninflamed mucosa of IBD patients.

    Palmieri O, Latiano A, Scimeca D, Bossa F, Corritore G, Latiano T, Andriulli A, Annese V


    2011; ():

    Dissecting the mucosal expression of human leucine-rich repeat family genes in inflammatory bowel disease patients.

    Palmieri O, Latiano A, Maglietta R, Palumbo O, Carella M, Ancona N, Bossa F, Andriulli A, Annese V


    2011; ():

    Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation.

    Lastella P, Patruno M, Forte G, Montanaro A, Di Gregorio C, Sabbà C, Suppressa P, Piepoli A, Panza A, Andriulli A, Resta N, Stella A


nuovo-css

  twitter   facebook   youtube